Tandem Diabetes receives Health Canada approval to market t:slim X2 insulin pump
Tandem Diabetes Care announced that it has received a Heath Canada Medical Device License for the t:slim X2 Insulin Pump. The t:slim X2 Pump features Dexcom G5 Mobile CGM integration, making it the only CGM-integrated insulin pump approved in Canada for making daily diabetes treatment decisions without fingersticks. The company plans to launch the t:slim X2 Insulin Pump on a province-by-province basis throughout the fourth quarter of 2018 pending the completion of pre-launch activities, including product registration with provincial health programs. The simple-to-use t:slim X2 Insulin Pump includes advanced features like a large color touchscreen, rechargeable battery, USB connectivity and watertight construction. As the only insulin pump integrated with Dexcom G5 Mobile CGM, dynamic glucose data can be easily accessed and shared using a compatible mobile device. The t:slim X2 Pump is up to 38% smaller than other insulin pumps and holds up to 300 units of insulin.